| Alayne Markland, | |
|
1717 6th Ave S, Birmingham, AL 35233-1801 | |
| (800) 822-8816 | |
| Not Available |
| Full Name | Alayne Markland |
|---|---|
| Gender | Female |
| Speciality | Geriatric Medicine |
| Experience | 26 Years |
| Location | 1717 6th Ave S, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356370498 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | 907 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Alabama Hospital | Birmingham, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Alabama Health Services Foundation, Pc | 1951213107 | 2344 |
News Archive
The conference, hosted by the European Commission's in-house science service, the Joint Research Centre (JRC), will discuss how research, technology and innovation can contribute to food for all. It will look at the best way to foster sustainability of food supply on a global scale.
Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced the pricing of its public offering of 7,000,000 shares of its common stock at a price of $6.50 per share.
Dapagliflozin, a drug that is already used to successfully treat type 2 diabetes (T2D) and prevent development of heart failure, can also be used to treat pre-existing heart failure, even in patients without T2D.
Researchers at the University of Pennsylvania's School of Medicine have discovered that implantable cardioverter-defibrillators (ICDs) - electric monitoring devices that deliver a lifesaving shock in the event of a cardiac arrest - help patients with heart problems live longer more active lives.
› Verified 8 days ago
| Entity Name | University Of Alabama Health Services Foundation, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
The conference, hosted by the European Commission's in-house science service, the Joint Research Centre (JRC), will discuss how research, technology and innovation can contribute to food for all. It will look at the best way to foster sustainability of food supply on a global scale.
Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced the pricing of its public offering of 7,000,000 shares of its common stock at a price of $6.50 per share.
Dapagliflozin, a drug that is already used to successfully treat type 2 diabetes (T2D) and prevent development of heart failure, can also be used to treat pre-existing heart failure, even in patients without T2D.
Researchers at the University of Pennsylvania's School of Medicine have discovered that implantable cardioverter-defibrillators (ICDs) - electric monitoring devices that deliver a lifesaving shock in the event of a cardiac arrest - help patients with heart problems live longer more active lives.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alayne Markland, 1717 6th Ave S, Birmingham, AL 35233-1801 Ph: () - | Alayne Markland, 1717 6th Ave S, Birmingham, AL 35233-1801 Ph: (800) 822-8816 |
News Archive
The conference, hosted by the European Commission's in-house science service, the Joint Research Centre (JRC), will discuss how research, technology and innovation can contribute to food for all. It will look at the best way to foster sustainability of food supply on a global scale.
Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced the pricing of its public offering of 7,000,000 shares of its common stock at a price of $6.50 per share.
Dapagliflozin, a drug that is already used to successfully treat type 2 diabetes (T2D) and prevent development of heart failure, can also be used to treat pre-existing heart failure, even in patients without T2D.
Researchers at the University of Pennsylvania's School of Medicine have discovered that implantable cardioverter-defibrillators (ICDs) - electric monitoring devices that deliver a lifesaving shock in the event of a cardiac arrest - help patients with heart problems live longer more active lives.
› Verified 8 days ago
Juan Mario Bernal, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 3680 Grandview Pkwy Ste 200, Birmingham, AL 35243 Phone: 205-971-7500 | |
Dr. William Randolph Maddox, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Princeton Ave Sw, Birmingham, AL 35211 Phone: 205-783-3000 Fax: 205-297-9411 | |
Jodie Ann Dionne, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 703 19th St S Bldg 206, Birmingham, AL 35233 Phone: 205-975-6530 | |
Dr. Karl Tullio Schroeder, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 817 Princeton Ave Sw Ste 199, Birmingham, AL 35211 Phone: 205-780-1920 Fax: 205-780-2345 | |
Dr. Deepti Bahl, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 6th Ave S, Birmingham, AL 35233 Phone: 205-934-9999 | |
Amitkumar Mehta, Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 1720 2nd Ave S # Np2540t, Birmingham, AL 35294 Phone: 205-996-8400 Fax: 205-934-1608 | |
Shana Monika Machado, D.O. Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011 |